Food and Drug Administration Oversight of Food Products Covered by Systems Recognition Arrangements; Draft Guidance for Food and Drug Administration Staff; Availability, 36559-36560 [2021-14789]
Download as PDF
36559
Federal Register / Vol. 86, No. 130 / Monday, July 12, 2021 / Notices
Administration for Community Living,
Washington, DC 20201, Attention:
Susan Jenkins.
FOR FURTHER INFORMATION CONTACT:
Susan Jenkins, Administration for
Community Living, Washington, DC
20201, 202–795–7369 or by email:
Susan.Jenkins@acl.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
The PRA requires Federal agencies to
provide a 60-day notice in the Federal
Register concerning each proposed
collection of information, including
each proposed extension of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, ACL is publishing a notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, ACL invites
comments on our burden estimates or
any other aspect of this collection of
information, including:
(1) Whether the proposed collection
of information is necessary for the
proper performance of ACL’s functions,
including whether the information will
have practical utility;
(2) the accuracy of ACL’s estimate of
the burden of the proposed collection of
information, including the validity of
the methodology and assumptions used
to determine burden estimates; (3) ways
to enhance the quality, utility, and
clarity of the information to be
collected; and
(4) ways to minimize the burden of
the collection of information on
respondents, including through the use
of automated collection techniques
when appropriate, and other forms of
information technology.
The Evidence Based Program Fidelity
Surveys will be used by ACL to evaluate
the fidelity with which ACL’s grantee
organizations, under the Older
Americans Act, implement the required
evidence-based programs. States that
receive Older Americans Act funds
under Title III–D are required to spend
those funds on evidence-based programs
to improve the health and well-being of
their clients and to reduce disease and
Number of
respondents
Respondent/data collection activity
Estimated Program Burden
ACL estimates the burden associated
with this collection of information as
follows:
Responses
per
respondent
Hours per
response
Annual burden
hours
Grantee: Program selection process and survey ............................................
Local Implementation Organization Survey .....................................................
103
412
1
1
2.00
0.67
206
275
Total ..........................................................................................................
515
1
0.93
481
Dated: July 6, 2021.
Alison Barkoff,
Acting Administrator and Assistant Secretary
for Aging.
[FR Doc. 2021–14700 Filed 7–9–21; 8:45 am]
BILLING CODE 4154–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2019–D–1997]
khammond on DSKJM1Z7X2PROD with NOTICES
injury. Since 2003, the aging services
network has been steadily moving
towards wider implementation of
disease prevention and health
promotion programs that are based on
scientific evidence and demonstrated to
improve the health of older adults. The
FY 2012 Congressional appropriations
law included, for the first time, an
evidence-based requirement related to
Title III–D funds.
The results of this information
collection will be used by ACL/AoA to:
• Effectively report its results to the
President, to Congress, to the
Department of Health and Human
Services and to the public.
• Assess the effectiveness of ACL and
its grantees in monitoring program
fidelity.
• Aid in program refinement and
continuous improvement.
To comment on this information
collection please visit the ACL website:
https://www.acl.gov/about-acl/publicinput.
Food and Drug Administration
Oversight of Food Products Covered
by Systems Recognition
Arrangements; Draft Guidance for
Food and Drug Administration Staff;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
VerDate Sep<11>2014
17:26 Jul 09, 2021
Jkt 253001
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a draft
guidance for FDA staff entitled ‘‘FDA
Oversight of Food Products Covered by
Systems Recognition Arrangements.’’
This draft guidance provides
recommendations related to the FDA’s
regulatory oversight activities for food
products imported from countries
whose food safety systems the FDA has
recognized in Systems Recognition
Arrangements (SRAs).
DATES: Submit either electronic or
written comments on the draft guidance
by September 10, 2021 to ensure that
the Agency considers your comment on
the draft guidance before it begins work
on the final version of the guidance.
ADDRESSES: You may submit comments
on any guidance at any time as follows:
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
E:\FR\FM\12JYN1.SGM
12JYN1
36560
Federal Register / Vol. 86, No. 130 / Monday, July 12, 2021 / Notices
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
khammond on DSKJM1Z7X2PROD with NOTICES
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2019–D–1997 for ‘‘FDA Oversight of
Food Products Covered by Systems
Recognition Arrangements; Draft
Guidance for FDA Staff.’’ Received
comments will be placed in the docket
and, except for those submitted as
‘‘Confidential Submissions,’’ publicly
viewable at https://www.regulations.gov
or at the Dockets Management Staff
between 9 a.m. and 4 p.m., Monday
through Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
VerDate Sep<11>2014
17:26 Jul 09, 2021
Jkt 253001
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
You may submit comments on any
guidance at any time (see 21 CFR
10.115(g)(5)).
Submit written requests for a single
hard copy of the draft guidance entitled
‘‘FDA Oversight of Food Products
Covered by Systems Recognition
Arrangements’’ to the Office of Strategic
Planning and Operational Policy, Office
of Regulatory Affairs, Food and Drug
Administration, 12420 Parklawn Dr.,
Element Building, Rm. 4148, Rockville,
MD 20857. Send one self-addressed
adhesive label to assist that office in
processing your request. See the
SUPPLEMENTARY INFORMATION section for
electronic access to the draft guidance.
II. Paperwork Reduction Act of 1995
FOR FURTHER INFORMATION CONTACT:
[Docket No. FDA–2019–D–5364]
Marla Hallacy, Office of Regulatory
Affairs, Division of Operational Policy,
Food and Drug Administration, 12420
Parklawn Dr., Rockville, MD 20857,
240–402–6674.
Submission of Plans for Cigarette
Packages and Cigarette
Advertisements (Revised); Guidance
for Industry; Availability
SUPPLEMENTARY INFORMATION:
AGENCY:
I. Background
HHS.
FDA is announcing the availability of
a draft guidance for FDA staff entitled
‘‘FDA Oversight of Food Products
Covered by Systems Recognition
Arrangements; Draft Guidance for FDA
Staff.’’ The draft guidance is part of
FDA’s larger effort to take a risk-based
approach to food safety to include
ensuring the safety of imported food,
consistent with the FDA Food Safety
Modernization Act. The guidance covers
FDA’s regulatory oversight activities for
food products covered by SRAs between
FDA and its foreign regulatory
counterparts. Currently, the FDA has
signed SRAs with food safety agencies
in Australia, Canada, and New Zealand.
The draft guidance is being issued
consistent with FDA’s good guidance
practices regulation (21 CFR 10.115).
The draft guidance, when finalized, will
represent the current thinking of FDA
on the topic of Systems Recognition
Arrangement implementation. It does
not establish any rights for any person
and is not binding on FDA or the public.
You can use an alternate approach if it
satisfies the requirements of the
applicable statutes and regulations.
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
FDA tentatively concludes that this
draft guidance contains no collection of
information. Therefore, clearance by the
Office of Management and Budget under
the Paperwork Reduction Act of 1995 is
not required.
III. Electronic Access
Persons with access to the internet
may obtain the draft guidance at either
https://www.fda.gov/regulatoryinformation/search-fda-guidancedocuments or https://
www.regulations.gov.
Dated: July 6, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for
Policy.
[FR Doc. 2021–14789 Filed 7–9–21; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
ACTION:
Food and Drug Administration,
Notice of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a revised
final guidance for industry entitled
‘‘Submission of Plans for Cigarette
Packages and Cigarette Advertisements
(Revised).’’ This is a revision to the
third edition of this final guidance,
which issued in February 2021, and is
intended to assist those required to
submit cigarette plans for cigarette
packages and cigarette advertisements
by providing content, timing, and other
recommendations related to those
submissions. FDA is revising this
guidance to reflect the May 21, 2021,
court order that postponed the effective
date of the final rule entitled ‘‘Tobacco
Products; Required Warnings for
Cigarette Packages and Advertisements’’
to July 13, 2022. Pursuant to the court
order, this revised guidance strongly
encourages entities to submit cigarette
plans to FDA as soon as possible after
publication of the final rule, and in any
event, by the recommended submission
date, which is currently September 13,
2021.
SUMMARY:
E:\FR\FM\12JYN1.SGM
12JYN1
Agencies
[Federal Register Volume 86, Number 130 (Monday, July 12, 2021)]
[Notices]
[Pages 36559-36560]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14789]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2019-D-1997]
Food and Drug Administration Oversight of Food Products Covered
by Systems Recognition Arrangements; Draft Guidance for Food and Drug
Administration Staff; Availability
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of availability.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
the availability of a draft guidance for FDA staff entitled ``FDA
Oversight of Food Products Covered by Systems Recognition
Arrangements.'' This draft guidance provides recommendations related to
the FDA's regulatory oversight activities for food products imported
from countries whose food safety systems the FDA has recognized in
Systems Recognition Arrangements (SRAs).
DATES: Submit either electronic or written comments on the draft
guidance by September 10, 2021 to ensure that the Agency considers your
comment on the draft guidance before it begins work on the final
version of the guidance.
ADDRESSES: You may submit comments on any guidance at any time as
follows:
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a
[[Page 36560]]
written/paper submission and in the manner detailed (see ``Written/
Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2019-D-1997 for ``FDA Oversight of Food Products Covered by Systems
Recognition Arrangements; Draft Guidance for FDA Staff.'' Received
comments will be placed in the docket and, except for those submitted
as ``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m.
and 4 p.m., Monday through Friday, 240-402-7500.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852, 240-402-7500.
You may submit comments on any guidance at any time (see 21 CFR
10.115(g)(5)).
Submit written requests for a single hard copy of the draft
guidance entitled ``FDA Oversight of Food Products Covered by Systems
Recognition Arrangements'' to the Office of Strategic Planning and
Operational Policy, Office of Regulatory Affairs, Food and Drug
Administration, 12420 Parklawn Dr., Element Building, Rm. 4148,
Rockville, MD 20857. Send one self-addressed adhesive label to assist
that office in processing your request. See the SUPPLEMENTARY
INFORMATION section for electronic access to the draft guidance.
FOR FURTHER INFORMATION CONTACT: Marla Hallacy, Office of Regulatory
Affairs, Division of Operational Policy, Food and Drug Administration,
12420 Parklawn Dr., Rockville, MD 20857, 240-402-6674.
SUPPLEMENTARY INFORMATION:
I. Background
FDA is announcing the availability of a draft guidance for FDA
staff entitled ``FDA Oversight of Food Products Covered by Systems
Recognition Arrangements; Draft Guidance for FDA Staff.'' The draft
guidance is part of FDA's larger effort to take a risk-based approach
to food safety to include ensuring the safety of imported food,
consistent with the FDA Food Safety Modernization Act. The guidance
covers FDA's regulatory oversight activities for food products covered
by SRAs between FDA and its foreign regulatory counterparts. Currently,
the FDA has signed SRAs with food safety agencies in Australia, Canada,
and New Zealand.
The draft guidance is being issued consistent with FDA's good
guidance practices regulation (21 CFR 10.115). The draft guidance, when
finalized, will represent the current thinking of FDA on the topic of
Systems Recognition Arrangement implementation. It does not establish
any rights for any person and is not binding on FDA or the public. You
can use an alternate approach if it satisfies the requirements of the
applicable statutes and regulations.
II. Paperwork Reduction Act of 1995
FDA tentatively concludes that this draft guidance contains no
collection of information. Therefore, clearance by the Office of
Management and Budget under the Paperwork Reduction Act of 1995 is not
required.
III. Electronic Access
Persons with access to the internet may obtain the draft guidance
at either https://www.fda.gov/regulatory-information/search-fda-guidance-documents or https://www.regulations.gov.
Dated: July 6, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2021-14789 Filed 7-9-21; 8:45 am]
BILLING CODE 4164-01-P